Martine Deprez: Leading with Mathematics, Listening, and Social Responsibility
FDA Approves Teclistamab Plus Daratumumab for Myeloma After ≥1 Prior Line — MajesTEC-3 Data Redefines the Standard of Care
Yvonne Awards 2026
Dean Crowe: Rally Kids - Then and Now
Servier Acquires Day One Biopharmaceuticals for $2.5B, Betting on Tovorafenib and the Pediatric Glioma Frontier
Douglas Flora Shares Key Takeaways from NCODA’s Global Oncology Congress
WeTrials Announces Partnership With GenomOncology and Belay Diagnostics
ARCAGEN Trial at ESMO Sarcoma and Rare Cancers Congress 2026: Genomic Alterations and Access to Precision Therapies
